Medical/Pharmaceuticals

CHOCOLATE TOUCH®, NEXT-GENERATION DRUG-COATED ANGIOPLASTY BALLOON FOR THE TREATMENT OF PERIPHERAL ARTERIAL DISEASE RECEIVES FDA APPROVAL

SINGAPORE, Nov. 11, 2022 /PRNewswire/ -- Genesis MedTech Group announced today that the Food and Drug Administration (FDA) has approved the Chocolate Touch® Drug-coated Balloon PTA Catheter, developed by TriReme Medical LLC, for the treatment of patients with peripheral artery disease in the s...

2022-11-11 14:00 2789

J INTS BIO, Novel Oral 4th Generation EGFR TKI 'JIN-A02' - Phase 1/2 IND approved by US FDA

- First patient expected in December 2022 SEOUL, South Korea, Nov. 10, 2022 /PRNewswire/ -- J INTS BIO announced on November 9th that it had received approval from the US FDA for its Phase 1/2 clinical trial of its Novel Oral 4th Generation EGFR TKI 'JIN-A02' in patients with advanced non-small ...

2022-11-11 10:30 2926

Bridgewest Group inks deal with Pfizer to acquire injectable manufacturing plant in Western Australia

MIAMI and PERTH, Australia, Nov. 11, 2022 /PRNewswire/ -- Global private investment firm,Bridgewest Group, recognized for developing innovative companies in life sciences, software, and deep tech, is expanding its portfolio. Today, Bridgewest Group has announced the signing of a definitive agree...

2022-11-11 10:07 4602

Oncoshot and Novotech Partner to Offer Cancer Data Insights

SINGAPORE, Nov. 11, 2022 /PRNewswire/ -- Oncoshot and internationally recognised contract research organisation (CRO) Novotech have begun a partnership to enhance clinical trial management success. This collaborative partnership will grant exchange and insights into real-time population data bet...

2022-11-11 10:00 5166

Harbour BioMed Enters into a License and Collaboration Agreement with Moderna

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, Nov. 10, 2022 /PRNewswire/ -- Harbour BioMed (the "Company", HKEX: 02142) today announced that Nona Biosciences, a subsidiary wholly owned by the Company, had entered into a license and collaboration agreement with ModernaTX, Inc. (NASDA...

2022-11-11 09:03 3352

Antengene Presents Promising Results from Four Preclinical Studies at the 2022 Society for Immunotherapy of Cancer Annual Meeting

-   Oral presentation highlights preclinical data with ATG-031, an in-house discovered anti-CD24 monoclonal antibody,tracking to an investigational new drug (IND) filing in H1:2023 -   Three poster presentations showcase preclinical data with three programs developed or discovered in-house,ATG-1...

2022-11-11 08:30 3474

Transcenta Presented Two Scientific Posters at SITC 2022 Annual Meeting

SUZHOU, China, Nov. 11, 2022 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces that it has presented...

2022-11-11 08:00 4615

Alma Academy was Successfully Held in Dubai with the Global Launch of Alma Duo

HONG KONG, Nov. 10, 2022 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", stock code: 1696.HK; together with its subsidiaries collectively referred to as the "Group"), a global consumer wellness group, is pleased to announce that, with over 500 physicians from 47 countries around th...

2022-11-10 23:58 5658

Alma Academy was Successfully Held in Dubai with the Global Launch of Alma Duo

HONG KONG, Nov. 10, 2022 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", stock code: 1696.HK; together with its subsidiaries collectively referred to as the "Group"), a global consumer wellness group, is pleased to announce that, with over 500 physicians from 47 countries around th...

2022-11-10 23:57 4080

YS Biopharma Announces US FDA Clearance Of IND Application For PIKA COVID-19 vaccine

NEW YORK, Nov. 10, 2022 /PRNewswire/ -- YS Biopharma Co., Ltd. ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing new generations of vaccines and therapeutic biologics for infectious diseases and cancer, to...

2022-11-10 22:30 3487

Novo Nordisk earns the Best Place to Work Certification in Pakistan for 2022

ISLAMABAD, Nov. 10, 2022 /PRNewswire/ -- Novo Nordisk been officially recognized as one of the Best Places to Work inPakistan and Best Place to Work for Women recognizing the company's achievements in promoting continuous learning at work and in fostering a high-performing workplace culture. Duri...

2022-11-10 21:56 2969

Prenetics Announces Record Third Quarter 2022 Financial Results and Raises Full Year 2022 Revenue and EBITDA Guidance

LONDON and HONG KONG, Nov. 10, 2022 /PRNewswire/ --  Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a global leader in genomic and diagnostic testing, today announced its unaudited financial results for the third quarter endedSeptember 30, 2022. Third Quarter 2022 and Rec...

2022-11-10 21:30 3862

CBC-backed ABio-X appoints pharmaceutical and healthcare veteran Dr. Jeffrey Jonas as CEO

WALTHAM, Mass., Nov. 10, 2022 /PRNewswire/ -- ABio-X, the Massachusetts-based biotech incubation platform focused on transformative medicines and breakthrough technologies, today announced the appointment ofJeffrey Jonas, M.D., as its Chief Executive Officer (CEO). Dr. Jonas brings with him mo...

2022-11-10 21:00 3529

Asieris Obtained IND Approval from US FDA for APL-1401, a New Drug for the Treatment of Moderately-to-Severely Active Ulcerative Colitis

SHANGHAI, Nov. 10, 2022 /PRNewswire/ -- Asieris Pharmaceuticals (688176), a global biopharma company specializing in discovering, developing and commercializing innovative drugs, announced today that the U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) appl...

2022-11-10 19:02 2523

Medical Device Connectivity Market Growth Helps Overcome Healthcare Professionals' Challenges

The MDC industry will witness growth due to the rise of MedTech and the incorporation of new technologies SAN ANTONIO, Nov. 10, 2022 /PRNewswire/ -- The need to alleviate pressure on healthcare professionals and increase patient care time boosts the demand for medical device connectivity (MDC), ...

2022-11-10 16:12 2568

"Global Innovation Challenge 2023" Inviting Participants in "Living Assistance Robot Contest" Designed to Help People with Disabilities "Walk Independently"

TOKYO, Nov. 10, 2022 /PRNewswire/ -- The Global Innovation Challenge Executive Committee (hereinafter referred to as "GIC Executive Committee") based inTokyo is pleased to announce the "Global Innovation Challenge 2023 Living Assistance Robot Contest" (hereinafter referred to as "GIC Contest") wi...

2022-11-10 14:00 3421

Ascentage Pharma Announces IND Approval in China for Phase I Study of APG-5918 in Patients with Advanced Solid Tumors or Hematologic Malignancies

SUZHOU, China and ROCKVILLE, Md., Nov. 9, 2022 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that its novel inhibitor of the embryonic ectoderm ...

2022-11-10 11:36 2669

Kintor Pharma Announces Oral Presentation at ASH 2022 Highlighting the Data from Novel Dual c-Myc/GSPT1 Degrader GT19715

SUZHOU, China, Nov. 9, 2022 /PRNewswire/ -- Kintor Pharmaceutical Limited ("KintorPharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, announced that the results from the novel dual c-Myc/GSPT1 degrader GT19715 have been s...

2022-11-10 09:12 2978

Monash University Implements Antibody Discovery Application by Utilizing the Berkeley Lights Beacon® Platform

EMERYVILLE, Calif. and MELBOURNE, Australia, Nov. 10, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced Monash University, one ofAustralia's leading universities, has implemented the use of the Berkeley Lights Beacon® system and Opto® Plas...

2022-11-10 07:57 3134

ALPINION MEDICAL SYSTEMS SHOWCASING THE LATEST INTELLIGENT ULTRASOUND TECHNOLOGY AT RSNA 2022

Unveiling Upgraded Top-Tier 'X-CUBE 90 on GPX' and Debuting Value Console 'X-CUBE 60' Unit Are Among the New-Generation of Diagnostic Ultrasound Systems to Be Demonstrated at the Radiological Society ofNorth America's Annual Medical Exhibition SEOUL, South Korea, Nov. 9, 2022 /PRNewswire/ -- ALP...

2022-11-10 04:50 3727
1 ... 504505506507508509510 ... 643